WALLINGFORD, Conn., Feb. 4, 2015 (GLOBE NEWSWIRE) -- via PRWEB - Z-Medica®, LLC, a leading developer and marketer of hemostatic devices, announces today that the sterility expiration date on its QuikClot Combat Gauze® products including QuikClot Combat Gauze, QuikClot Combat Gauze XL, QuikClot Combat Gauze TraumaPad, and QuikClot Combat Gauze LE is now five years.
"This is a significant development for our QuikClot Combat Gauze family of products," said Z-Medica President and CEO, Stephen J. Fanning. "Our number one mission is saving lives and stopping bleeding of those who are seriously injured. A longer shelf life not only provides our customers with better cost efficiencies and longer storage ability, but also provides an increased assurance of supply with no negative impact to quality or efficacy."
All QuikClot Combat Gauze products will reflect the extended expiration date effective immediately. Customers should adhere to the expiration date on the labeling for existing supply of products. QuikClot Combat Gauze packaged and labeled with a three-year expiration date are not covered by the recent five-year testing.
About Z-Medica®, LLC
Z-Medica, LLC is a medical device company founded in 2002 developing fast acting, easy to use, hemostatic products that stop bleeding wherever it occurs, making it possible to save lives and improve patient outcomes. Based on tests conducted by the Naval Medical Research Center and the U.S. Army Institute for Surgical Research, the Committee on Tactical Combat Casualty Care (CoTCCC) recommended QuikClot Combat Gauze® as the hemostatic agent s the hemostatic dressing of choice on the battlefield for compressible hemorrhage not amenable to tourniquet use or as an adjunct to tourniquet removal if evacuation time is anticipated to be longer than 2 hours. QuikClot® products are developed and manufactured in the United States. Z-Medica, LLC is a privately-held company based in Wallingford, CT. For more information, visit http://www.quikclot.com
Company Contact:
Dave Schemelia / EVC Group
dave(at)evcgoup(dot)com
609-468-9325
This article was originally distributed on PRWeb. For the original version including any supplementary images or video, visit http://www.prweb.com/releases/2015/02/prweb12491724.htm